Humana (HUM) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Humana (HUM) reported $29.12 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 13.2%. EPS of -$2.16 for the same period compares to -$0.11 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $28.82 billion, representing a surprise of +1.05%. The company delivered an EPS surprise of +4.42%, with the consensus EPS estimate being -$2.26.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Humana performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Benefits Expense Ratio - Consolidated: 91.5% versus 91.3% estimated by eight analysts on average. Medical Membership - Group Medicare Advantage: 545.7 thousand versus 544.72 thousand estimated by five analysts on average. Medical Membership - Medicare stand-alone PDP: 2.29 million compared to the 2.26 million average estimate based on five analysts. Medical Membership - Individual Medicare Advantage: 5.66 million versus the five-analyst average estimate of 5.67 million. Revenues- Premiums: $27.75 billion compared to the $27.37 billion average estimate based on 10 analysts. The reported number represents a change of +10.4% year over year. Revenues- Investment income (loss): $297 million versus the nine-analyst average estimate of $317.22 million. The reported number represents a year-over-year change of +1%. Revenues- Services: $1.17 billion compared to the $1.07 billion average estimate based on eight analysts. The reported number represents a change of +12.1% year over year. Revenue- CenterWell: $5.13 billion versus $4.89 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +8.9% change. Revenues- Consolidated- Premiums- Specialty benefits: $238 million versus the five-analyst average estimate of $238.44 million. The reported number represents a year-over-year change of -4.4%. Revenues- Consolidated- Premiums- State-based contracts and other: $3.16 billion versus the five-analyst average estimate of $2.80 billion. Revenue- Insurance: $28.17 billion compared to the $27.67 billion average estimate based on five analysts. The reported number represents a change of +10.2% year over year. Insurance segment - Intersegment revenues- Services: $1 million compared to the $4.60 million average estimate based on five analysts. The reported number represents a change of 0% year over year. View all Key Company Metrics for Humana here>>>Shares of Humana have returned -7.2% over the past month versus the Zacks S&P 500 composite's +4.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Humana Inc. (HUM): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks